For research use only. Not for human or veterinary use. Not for diagnostic or therapeutic use.
Menu
Reconstitution calculator

Cited duration

CJC-1295 with DAC study duration

The study cited for CJC-1295 with DAC lasted 7 weeks. It is a study duration, not a recommended cycle, and no off period is stated. Population in the source: Healthy adults aged 21 to 61, two randomized double-blind placebo-controlled ascending-dose trials (28-day single-dose study and 49-day multiple-dose study); CJC-1295 with DAC.[1]

Human trial

Sam, MBA · Human-researched and AI-assisted with full editorial review. · Last reviewed October 2026

About the source: The 49-day study (7 weeks) gave two or three weekly or biweekly doses. Study duration, not a recommended cycle. The study used the long-acting DAC form (estimated half-life 5.8 to 8.1 days), not the no-DAC form; IGF-I stayed above baseline up to 28 days after multiple doses.

Study duration

7 weeks[1] Human trial

Duration of the cited study. It describes the source and is not a recommended cycle; no off period is stated. Source

References

Numbered sources used on this page. Markers in the text link here.

  1. pubmed.ncbi.nlm.nih.gov Human trial